Victory Crown Insights — Research-informed analysis on behavioral health, workforce, and leadership for health executives. Published by Victoria Williams, Ph.D.
Most health systems know how to add a priority. Few have built an equally credible way to stop funding one.
The result is strategic accumulation.
New programs, technologies, service lines, reporting requirements, and transformation initiatives are layered onto an operating system that has not released the money, workforce, technology capacity, or management attention tied to older commitments. Leaders then describe the resulting overload as an execution problem, even though the deeper failure often occurred earlier, when the organization avoided deciding what would no longer receive resources.
Stopping a priority should not be a blunt cost-cutting exercise. It is a resource-allocation decision that must weigh clinical benefit, equity, strategic relevance, total resource intensity, implementation performance, available alternatives, and opportunity cost.
The defensible question is not whether a program is good.
It is whether continuing to fund it remains the best available use of scarce resources compared with what those resources could accomplish elsewhere.
Why Health Systems Keep Funding Too Much
Annual planning processes usually reward addition.
Leaders propose new work. Business cases justify investment. Governance forums evaluate projects one at a time. Once programs enter the operating model, however, they receive much less scrutiny.
Existing commitments become embedded in budgets, contracts, staffing models, technology configurations, workflows, and stakeholder relationships. Historical funding gradually begins to look like an entitlement rather than a decision that should periodically be reconsidered.
This asymmetry is reinforced by visibility.
The beneficiaries of an existing program are identifiable. Clinicians know the service. Patients may depend on it. Leaders may have sponsored it. Staff may have built careers around delivering it.
The beneficiaries of an alternative use of those same resources are often less visible because that alternative has not yet been funded.
Ending an existing service therefore creates a concentrated and identifiable loss. Continuing it conceals the opportunity cost.
A weak allocation process will predictably favor the status quo even when better uses of the same resources exist.
Priority-setting research reflects this problem. Allocation decisions continue to rely heavily on historical patterns and ad hoc judgment, while formal disinvestment processes remain relatively uncommon despite broad agreement that credible decisions should use explicit criteria, examine opportunity cost, engage stakeholders, and demonstrate fairness and transparency.
Begin With the Portfolio, Not the Program
A stop-funding decision cannot be judged in isolation.
A program can produce genuine benefit and still be a lower-value use of scarce resources than the alternatives competing with it.
That distinction is critical.
If leaders ask only whether a program works, most established programs will find some evidence in their defense. The more strategic question is how much value the program produces, for whom, at what total cost, with what level of evidence, and relative to which realistic alternative.
Health systems should therefore review priorities as a portfolio.
Existing commitments, proposed investments, and credible alternatives should be considered within a defined resource envelope rather than evaluated as unrelated business cases.
Program Budgeting and Marginal Analysis was designed around this logic: examine where resources are currently committed, then assess the gains and losses associated with moving resources at the margin. Health-sector disinvestment reviews have identified this approach, along with health technology assessment, among the more established formal methods for supporting resource-allocation decisions.
The resource envelope also has to include more than money.
Nursing capacity, specialist time, analytic support, digital development, clinic space, project-management capability, and executive attention may be more constraining than the operating budget.
A program can therefore remain financially affordable while becoming strategically unaffordable.
If maintaining it consumes the workforce, technology capacity, or leadership attention required for a more consequential priority, the opportunity cost is real even if no budget line appears overspent.
Use Explicit Criteria Before Naming Targets
The organization should establish its decision criteria before deciding which programs will be reviewed.
Otherwise, the process becomes vulnerable to a predictable distortion: criteria are adjusted after the fact to protect favored services or produce a preferred result.
That destroys legitimacy.
The criteria should be limited enough to apply consistently and broad enough to capture forms of value that financial return alone will miss.
At minimum, leaders should examine clinical effectiveness and safety; population need and equity; strategic and regulatory necessity; total cost and resource intensity; reach and utilization; implementation performance; availability of better alternatives; and the consequences of withdrawal.
Evidence quality should also be considered separately from the direction of the evidence.
Weak evidence that a program is ineffective is not the same as strong evidence that it is ineffective. But uncertainty should not become a permanent justification for continued funding either.
Where evidence is insufficient, the organization can create a time-limited continuation period tied to explicit performance expectations and a future decision date.
No single numerical score should make the decision automatically.
Weighted criteria can improve consistency and expose tradeoffs, but apparent mathematical precision can hide weak evidence and contested organizational values. The score should support judgment, not replace it.
Distinguish Low Value From Poor Execution
Underperformance can mean very different things.
The intervention itself may produce little benefit.
The target population may be wrong.
The delivery model may be poorly designed.
Implementation may be incomplete.
The service may work but cost too much compared with another approach.
The program may also be clinically valuable while consuming a scarce resource needed for a more urgent priority.
Treating those conditions as equivalent produces poor decisions.
Before withdrawing resources, leaders should determine whether the underlying theory remains credible and whether the program received a fair operational test.
A strategy cannot reasonably be declared ineffective because the organization never staffed it adequately, integrated it into workflows, provided the necessary technology, or measured outcomes reliably.
But the opposite error is equally dangerous.
Prior investment does not create an obligation to rescue a program indefinitely.
The relevant question is whether a feasible correction exists, whether the organization is willing to provide what that correction requires, and whether the expected value justifies additional investment within a defined period.
That diagnosis creates several legitimate outcomes: continue the program, improve it under explicit conditions, redesign or narrow it, replace it, or stop funding it.
A sixth option—continue while gathering better evidence—should always have an expiration date.
Otherwise uncertainty becomes a permanent shelter for weak performance.
The Problem Is Often Architectural Before It Is Financial
Resource-allocation decisions are frequently treated as finance exercises.
They are also tests of organizational architecture.
The Architecture Index™ examines four interconnected conditions that shape whether strategy becomes sustained organizational practice: Leadership, Governance, Culture, and Institutionalization.
Those conditions become visible when an organization attempts to stop funding something.
Leadership determines whether executives are willing and able to establish real priorities rather than adding commitments without resolving the tradeoffs among them.
Governance determines who has authority to reconsider existing investments, what evidence is required, how competing interests are handled, and who ultimately makes the decision.
Culture determines whether leaders and clinicians can openly question established programs, challenge executive-sponsored initiatives, and discuss opportunity cost without being treated as disloyal or resistant.
Institutionalization determines whether resource reallocation is a routine management discipline or something the organization attempts only during financial distress.
A health system can therefore possess a sophisticated financial model and still be unable to disinvest effectively.
If no one has clear authority to stop a program, if challenging historical priorities is culturally unsafe, or if reassessment depends entirely on a particular executive forcing the issue, the constraint is not analytical capability alone.
It is architectural.
Protect Equity Without Making Every Program Permanent
Equity must be examined directly because aggregate utilization and financial measures can make programs serving smaller or marginalized populations appear inefficient.
A service may have limited volume while addressing severe need, removing a structural barrier, or preventing harms that conventional return calculations undervalue.
That matters.
But equity should not become an exemption from evaluation.
Leaders should ask whether the program actually reaches the population it is intended to serve, whether benefits are distributed fairly, whether access barriers remain, and whether a different delivery model could accomplish the same equity objective more effectively.
Protecting the objective does not require protecting the current mechanism indefinitely.
This distinction is especially important when programs become symbolically associated with organizational commitments.
A decision to redesign a service serving a vulnerable population should not automatically be interpreted as abandoning the population. But leadership bears a higher burden to demonstrate that the alternative preserves or improves access, quality, and outcomes.
Transition harms must therefore be included explicitly in the analysis.
Abrupt withdrawal can interrupt care, increase travel or waiting time, shift burden to families, create workforce disruption, or push demand into emergency settings.
Those consequences are part of the resource-allocation decision, not implementation details to be considered afterward.
Build a Process That Can Withstand Pressure
Disinvestment is politically and emotionally difficult because losses are concentrated.
The patients, clinicians, leaders, and partners affected by a withdrawal decision are identifiable. The people who may benefit from the reallocated resources often are not.
That makes process legitimacy essential.
A technically defensible decision can still fail if stakeholders believe the criteria were inconsistent, the evidence was selectively applied, or the outcome was predetermined.
Research on healthcare disinvestment repeatedly identifies stakeholder involvement as both an important facilitator and a significant implementation challenge.
A credible process should publish the criteria, identify conflicts of interest, apply comparable evidence standards across programs, document the rationale for decisions, and establish a defined route for challenge.
Participation should include the people needed to expose different consequences: clinical experts, operational leaders, finance, patients, community representatives, and other affected stakeholders.
Their role is not to produce unanimity.
It is to improve the quality of the decision.
That means surfacing information, challenging assumptions, identifying unintended consequences, and making contested values visible.
Final authority must still remain clear.
Committees that can study and recommend indefinitely but cannot make or trigger a decision generate analysis without reallocation.
Governance should specify who decides, what evidence is required, when the decision must occur, under what circumstances reconsideration is allowed, and what happens to the resources once they are released.
Stop Funding Through Managed Transition
A stop-funding decision is not complete when approval is withdrawn.
Contracts, staffing arrangements, patient relationships, technology dependencies, referral pathways, and clinical workflows still have to be unwound, transferred, or redesigned.
The transition plan should specify the effective date, clinical continuity requirements, workforce actions, communication responsibilities, financial-release schedule, technology implications, referral arrangements, and measures for unintended harm.
Released resources should also remain visible.
If resources simply disappear into general operations, clinicians and affected communities experience the loss without seeing the strategic value created by the decision.
Where possible, leaders should make the reallocation explicit: what service, population, capability, or strategic priority will now receive the resource that was previously committed elsewhere?
That visibility matters because it turns disinvestment from subtraction into reallocation.
The system must also verify that the change actually occurred.
A formal decision to stop funding does not guarantee that practice stops.
Utilization may continue. Costs may shift instead of disappearing. Work may migrate into another department. Staff may reproduce the service informally. Demand may surface elsewhere in the system.
Evidence reviews have found that fewer than half of empirical disinvestment studies reported reductions in the targeted low-value services, illustrating the gap between making a decision and changing organizational practice.
This is where institutionalization matters again.
The organization has not completed the decision until the old practice has actually changed, the resources have genuinely moved, and unintended consequences are being monitored.
The Stop-Funding Test
Before continuing, redesigning, or withdrawing a priority, leaders should be able to answer four sets of questions.
Leadership
Is this priority still important enough to justify the resources it consumes?
What would the organization be able to accomplish if those resources were released?
Are senior leaders prepared to make the tradeoff explicit rather than preserving competing priorities simultaneously?
Governance
Who has final authority to continue, redesign, or stop the program?
Are the criteria and evidence requirements established before the decision?
Is there a defined decision date, challenge process, and transition authority?
Culture
Can clinicians, operational leaders, and patients raise concerns about the program without the discussion becoming politically unsafe?
Can an executive-sponsored or historically protected program be evaluated under the same standards as other investments?
Are stakeholders able to surface harms and tradeoffs without assuming participation guarantees preservation?
Institutionalization
Does the organization routinely reassess existing investments, or only during budget crises?
If the program stops, will utilization, cost, patient outcomes, workforce effects, and equity be monitored afterward?
Can the organization demonstrate where the released resources actually went?
Will the decision survive leadership turnover, stakeholder pressure, and the gradual return of old practices?
If leaders cannot answer those questions convincingly, the organization may not yet have a stop-funding problem.
It may have an organizational architecture problem that prevents stop-funding decisions from becoming credible, repeatable, and durable.
The Strategic Implication
Health systems should stop funding priorities through a repeatable allocation discipline, not a periodic search for cuts.
That discipline should compare the portfolio, use explicit criteria, distinguish weak value from weak execution, protect equity, account for opportunity cost, clarify decision authority, and manage the transition after resources are withdrawn.
The hardest part is accepting that a program can produce real benefit and still not deserve continued funding.
Scarcity makes comparative value unavoidable.
Leaders who refuse that comparison do not avoid rationing. They ration implicitly through waiting, understaffing, delayed investment, unmet demand, and organizational overload.
The deeper implication is architectural.
Organizations need leadership capable of making explicit tradeoffs, governance capable of authorizing them, a culture capable of discussing them honestly, and institutionalized processes capable of making resource reassessment routine rather than exceptional.
A credible health system does not promise to preserve every existing commitment.
It promises to make difficult choices consistently, transparently, and with safeguards for the people affected.
Strategy becomes real when the organization can stop work as deliberately as it starts it.
Schedule a confidential conversation: https://www.victorycrownconsulting.com/inquire
© 2026 Victory Crown Consulting. All rights reserved. Originally published at victorycrownconsulting.com/insights.
